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Introduction
Although standardised age rates of stroke mortality are decreasing across the world, the global burden of stroke (including years lived with disability) are substantial and continuing to increase. 1 Improvements in medical treatment have increased the number of people surviving and living with the consequences of stroke. 2 Depression is particularly problematic and persistent after stroke, with high risk of relapse, even after a long period of remission. 3 People with depression after stroke experience greater impairment, including more substantial reductions in activities of daily living, 4 5 6 poorer quality of life 7 and increased mortality, 8 9 compared with non-depressed stroke patients. Untreated poststroke depression often impairs physical rehabilitation and recovery. 10 11 12 Depression has also been proposed to have a bidirectional relationship with stroke, being cause by stroke and also acting as a risk factor for stroke itself. 13 Despite the clear importance of depression after stroke, there is evidence suggesting it is under-recognised. 14 Beyond depression, other mood disorders have been much less extensively investigated. For example, the proportion suffering dysthymia, anxiety disorders or adjustment disorder is essentially unknown. Further to this, although there has been considerable interest in risk factors for post-stroke depression the most commonly investigated factors, namely aphasia and lesion location, remain controversial. Four previous systematic reviews or meta-analyses have examined the importance of lesion location with varying results. 15 16 17 18 All these reviews included heterogeneous types of depression, defined by self-report scales alone as well as robust interviews. Indeed despite many narrative reviews of post-stroke depression, none have focussed on robust interview based studies. 19 Two previous meta-analyses also considered the prevalence of depression post stroke, but did not confine the studies included based on robust interviews and were not able to investigate the prevalence of other mood disorders that may also be problematic post stroke (e.g. dysthymia, anxiety disorders or adjustment disorder). 20 21 One recent meta-analysis looked at anxiety disorders with similar limitations. 22 An unresolved question is whether mood disorders remain elevated during rehabilitation and discharge back to the community. If rates of depression and anxiety remain high then clinicians should continue to monitor such patients long after their inpatient treatment has concluded. We therefore set out to address the shortcomings in the literature and establish the
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4 prevalence of mood disorders (major depression, minor depression, dysthymia) as well as adjustment disorder, anxiety disorders and combined mood disorders post stroke. We also set out to examine the underlying influences upon depression by stratifying studies by setting, aphasia, lesion location, family history, personal history and time since stroke.
Methods
This review was conducted in accordance with the Meta-analysis of Observational Studies in Epidemiology (MOOSE) 23 guidelines and with reference to the preferred items for reporting systematic reviews and meta-analysis (PRISMA) statement 24 following a predetermined protocol available on request (PRISMA criteria #5). . MOOSE and PRISMA compliance checklists are available in appendix 3 and 4.
Eligibility criteria
Studies were included that 1) reported the prevalence of depression and related mood or anxiety disorders in adults who had experience a stroke within a consecutive, random or convenience sample on at least one occasion according to the definitions within the ICD or DSM criteria (typically two weeks). This included cross sectional and longitudinal studies. 2) Determined the presence of depression, mood and anxiety disorders through robust interview including structured, semi-structured or a clinical interview applied by a researcher, trained clinician or health professional. 3) Were conducted in acute (inpatient hospital) care, rehabilitation and in the community. Unless predefined by authors, we defined acute care as 0-1 months, in accord with typical length of stays after stroke of 14-21 days. 25 26 Stroke itself was defined by ICD160-169 (non-traumatic intracranial hemorrhage, cerebral infarctions and occlusion and stenosis of cerebral or pre-cerebral vessels without infarction).
We considered the following disorders meeting the following DSM research criteria: A. anxiety disorder was examined by all such studies but a minority also considered agoraphobia, panic disorder, agoraphobia, OCD and social phobia) by DSM (III,IIIR,IV) criteria.G. Mood comorbidity that is a combination of depression and anxiety with or without adjustment disorder.
Studies were excluded that a) relied upon self-report or observer scales to quantify depression including those using a two-step procedure of an initial scale and then interview in those who screen positive in step 1. b) Were not representative of the general stroke population including those among selected samples (e.g. from interventional trials or those below the age of 18). c) Studies only reporting lifetime prevalence of mood disorder. We also excluded duplicate publications; that is two or more studies on the same sample collected at the same time point. However we allowed multiple analyses by time from one publication (for example assessment at 1, 3 and 12 months). However, we performed restrictor moderator analysis in order to address the influence of this, counting only unique individuals. We did not place any language restriction upon eligible studies. We refer to the period prevalence (for example the last two weeks) hereafter simply as "prevalence".
Literature search
Two independent authors (AJM, NM) conducted searches of Medline (Pubmed), PsycINFO and Web of Knowledge from inception to June 2015. We used the key words (stroke or cerebrovascular or hemorrhage or cerebral infarctions) and (depression, major depression, major depressive disorder,
Two authors (JSG, AJM) conducted the risk of bias assessment using a four point quality rating and a five point bias risk was applied to each study as used in a recent similar prevalence study. 27 The quality rating score was based on study sample size, study design, study attrition, follow-up (if any) and method of dealing with possible confounders with the following scale: 1 = low quality 2 = lowmedium quality 3 = medium -high quality 4 = high quality. The bias rating score evaluated possible bias in assessments of results as influenced by consideration of setting, aphasia, interview method and sampling method. Bias was rated with the following score: 0 = no appreciable bias risk 1 = low bias risk 2 = low to medium bias risk 3= medium to high bias risk 4 = high bias risk. Finally the sampling method was evaluated for each study, as this influences the interpretation of prevalence data (see below). Any area of disagreement was resolved by two supervisors (AJM, NM).
Data extraction
Three independent authors (JG, BS, AJM) conducted all data extraction using a standard extraction form. The data extracted included study design, setting, participant characteristics (number, mean age, gender, details of any cognitive assessment e.g. Mini-Mental State Examination (MMSE)), type of mood disorder and classification criteria used, details of stroke, (including time since the event, type and hemispheric laterality) the prevalence of aphasia and family and personal history of mood disorders studies.
Statistical Analysis
Prevalence and relative risk meta-analyses were calculated. Heterogeneity was defined by I² statistic Which describes the percentage of variation across studies that is due to heterogeneity rather than chance and does not inherently depend upon the number of studies considered (Higgins et al., 2003) . 28 Due to the moderate and high inconsistency/ heterogeneity (I 2 of ≥80% = moderate ≥90% = high respectively) data was pooled using DerSimonian-Laird random effects meta-analysis with StatsDirect (version 2.7.7). In order to assess for publication bias we conducted the Harbord bias test. 29 Harbord test maintains the power of the Egger test whilst reducing the false positive rate.
In assessing the association between linear variables we used spearman correlation with adjusted R 2 .
Regarding predictors and correlates of mood disorder we stratified sub analysis and meta-regression.
We examined the effect of age, gender, setting, stroke type and time since stroke. The failsafe
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A C C E P T E D M A N U S C R I P T 7 number of studies that would justify meta-analysis in any subsection, was set at three, according to convention of the Cochrane collaboration. A meta-regression was conducted for the effect of time since stroke on prevalence using Restricted Maximum Likelihood (REML) estimate of between study variance explained by time with Knapp-Hartung modification for small samples
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Results
The initial searches yielded 2658 hits on pubmed, 1,168 hits on Web of Knowledge and 883 on PsychINFO (1833 after removal of duplicates) but upon review only 419 were relevant after initial screening (see PRISMA flowchart appendix 2). From 419 articles reviewed in detail following application of the eligibility criteria: a total of 108 publications were included that examined the prevalence of depression among 14,220 unique patients who had experienced a stroke (references of included articles are presented in appendix 5). Details of the search strategy and breakdown of the study characteristics are summarized in figure 1 . Considering each assessment in time as separate analysis meant that depression was examined on 147 occasions from 2 days to 7 years after stroke (mean 6.87 months) across the studies.
Insert figure 1 here
Study and participant characteristics
Of 147 included analyses (in 108 publications), 33 took place in an acute hospital setting, 43 in rehabilitation settings and 69 in the community or hospital outpatient settings (see appendix table 2 for full details). The mean age of stroke patients across all studies was 65.0 years, and 43.8% were female. 42 studies conducted the MMSE in their sample and the mean MMSE score among 5539 patients was 25.8. Of the included studies, 16 offered prospective assessment of depression at least two points after stroke. 128 analyses reported on the prevalence estimates of major depression (n=15,573), 65 on minor depression (n=9720), 75 on major or minor depression combined (n=10,799), 25 reported rate of anxiety disorders (n=2974), largely mixed types or generalized anxiety disorder), and 18 reported rates of dysthymia (n= 3320), and 8 reported on adjustment disorder (n= 1849). A subset of analyses looked at regional stroke location, most commonly hemisphere laterality (N=44, n=6115). 55 analyses considered only cerebral ischaemic stroke (n=7386), the remainder considered mixed types of stroke. Of studies reporting types of stroke approximately 83% had ischaemic thromboembolic stroke. 95 analyses assessed and excluded people with aphasia and only 5 studies specifically reported on the prevalence of depression in stroke patients with aphasia. Full details of each study are presented in online appendix table 2.
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9 Quality assessment of the included studies is summarized in online appendix 2. 24.1% of studies had a low quality. The most common reasons for low quality were using an unstructured clinical interview, not fully reporting data and low sample size. Regarding risk of bias, 13% of studies had a high risk of bias. The most common risk identified among the studies included not reporting blinding of assessments, using single stroke types, not reporting pre-defined cut-offs for diagnostic thresholds, and a lack of information concerning drop outs.
Overall pooled prevalence of any disorder of mood or emotion
The overall pooled prevalence of any disorder of mood or emotion across all settings was 27.0%
(95% CI = 21.8% to 32.3% 
Insert table 1 here
Prevalence of Depression
DSM Major Depression
In total, the pooled prevalence of MDD across 128 analyses (n=15,573) measured a mean of 6.9 months after stroke, was 17.7% (95% CI = 15.6% to 20.0%,). There was evidence of publication bias in this sample with a lower than expected number of small studies showing a small proportion with depression (p = 0.01). The prevalence of MDD among studies including people with aphasia was 14.3% (95% CI = 11.1% to 17.8%) and 19.9% (95% CI = 17.3% to 22.6%) in those analyses with aphasia excluded. When restricted to a non-overlapping sample of 12,723 unique individuals in 98 studies, then the prevalence was 19.2% (95% CI = 16.6% to 22.0%).
It was possible to pool 32 analyses (n=3838) examining MDD in the acute post-stroke period, a mean of 3.4 weeks after stroke. This established a pooled prevalence of post-stroke MDD of 18.1% (95% CI = 14.4% to 22.1%) (figure 2). Sub group analysis revealed that this estimate was not statistically different in studies that included or excluded aphasic patients or restricting the analyses to nonoverlapping samples of unique individuals. Next, we pooled 42 analyses (n=3444) examining MDD in rehabilitation settings, a mean of 7.1 months after stroke. The prevalence of post-stroke MDD was 
DSM Minor Depression
In total 65 analyses (n=9720) examined MnD across all settings establishing a prevalence of 13 
Anxiety disorder
The pooled prevalence of anxiety disorder across all settings (N=25, n=2974) was 9.8% (95% CI = 5.9% to 14.8%). The pooled prevalence in acute setting was 10.7% (95% CI = 3.8% to 20.4%), whilst 7.0% (95% CI = 3.4% to 11.7%) and 12.8% had anxiety in rehabilitation and community setting respectively.
Adjustment disorder
The pooled prevalence of adjustment disorder was calculated from 8 analysis (n=1849) across all settings at 6.9% (95% CI = 4.6% to 9.7%). Due to limited data it was not possible to conduct subgroup analysis among people with adjustment disorder across different settings.
Dysthymia
The pooled prevalence of dysthymia across all settings was 3.6%. The pooled prevalence was highest in acute settings (8.4%, 95% CI = 1.59% to 19.9), followed by rehabilitation (5.1%, 95%
CI=1.73% to 10.1) and community settings (2.3%, 95% CI= 1.1-3.9%).
Predictors of Post-Stroke Depression
The Effect of Hemispheric Laterality
In patients with a stroke affecting the left hemisphere (across all time periods and settings) (N=19, n=1887) MDD was present in 34.3% (95% CI = 24.8% to 44.4%). This was significantly higher than the rate of MDD after stroke irrespective of lesion site (17.7%, 95% CI = 15.6% to 20.0%, see above).
A relative risk analysis of MDD after left hemisphere lesions vs MDD after non-left hemisphere lesions was conducted and had no evidence publication bias or hetergeneity (figure 3). Given the low heterogeneity a fixed effects meta-analysis showed that the risk of MDD was 1.50 (95% CI = 1.29 to 1.74, Chi² = 27.4, P < 0.0001) following left vs non-left lesions. This effect was also significant using random effects meta-analysis (data not shown).
Insert figure 3 about here
20 analyses involving 3618 patients examined whether the prevalence of any depressive disorder was influenced by hemishpere laterality. In those with a left hemisphere stroke the rate of any depressive disorder was 41.1% (95% CI = 37.4% to 44.8%). This was significantly higher than the rate of any depressive disorder depression after stroke irrespective of lesion site (33.5% (95% CI = 30.3% to 36.8% see above). A relative risk analysis of any depressive disorder after left hemisphere lesions vs depression after non-left hemisphere lesions was conducted and had no evidence publication bias or hetergeneity. On fixed effects meta-analysis the risk of any depressive disorder
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T 12 was 1.26 (95% CI = 1.16 to 1.37, Chi² = 27.4, P < 0.0001) following left vs non-left lesions. This effect remained statistically significant using random effects meta-analysis (data not shown).
The Effect of Aphasia
Only four analysis involving 113 patients examined MDD in stroke patients with clearly defined aphasia (all settings and all time periods) were available and the pooled prevalence of MDD in aphasic patients was 30.5% (95% CI = 10.1% to 56.1%). There was insufficient data to perform a relative risk analysis because only two studies reported on the rate of depression in stroke patients with vs without aphasia in their sample.
Only five analysis involving 211 patients examined any depressive disorder in stroke patients with aphasia (all settings and all time periods). The prevalence of any depressive disorder in aphasic patients was 52.2% (95% CI = 34.9% to 69.3%) There was a 50% increased risk of depression in stroke patients with vs without aphasia (RR 1.50, 95% CI = 1.28 to 1.75).
The Effect of Family History of Mood Disorders
Eight studies involving 1099 patients examined the influence of family history on the prevalence of depression after stroke. In those with a family history there was a 27.3% rate (95% CI = 17.4% to 38.5%) of any depressive disorder vs 20.0% (95% CI = 13.2% to 27.6%) in those without a family history. The relative risk of depression was 1.44 (95% CI = 1.15 to 1.80).
The Effect of Past History of Mood Disorders
Eight studies involving 1058 patients examined the influence of family history on the prevalence of depression after stroke. In those with a past history there was a 22.4% (95% CI = 15.2% to 30.5%) of any depressive disorder vs 12.8% (95% CI = 9.9% to 16.1%) in those without a personal past history.
The relative risk of depression was 1.80 (95% CI = 1.36 to 2.38).
The Effect of Time Since Stroke
The most frequent occasion after stroke when depression was measured was 12 months, when the prevalence of MDD was 13.4% (95% CI = 9.6% to 17.8%) and the prevalence of any depressive disorder was 23.9% (95% CI = 18.5% to 29.8%). We conducted a meta-regression concerning the settings. These prevalence estimates are similar to the rates of major depression defined by interview in large scale meta-analyses in primary care (17·3%, 12·2% to 23·1%) 30 and cancer (14·9%, 12·2-17·7%). 31 However, it is important to recognise major depression is only one of several important mood disorders. Minor depression and other non-major depressions are associated with significant burden 32 and previous meta-analyses have failed to consider the range of mood disorders. We found 65 analyses involving 9720 patients that examined MnD, across all settings and found that MnD was present in 13.1% (13.3% in unique patient analysis) although it was particularly high as 16.7% in rehabilitation settings. An additional 3.1% had dysthymia and 6.9% had adjustment disorder. Overall we estimate that at least one in three have clinical depression (any depressive disorder) on any particular day after stroke. The clinical implication is that clinicians should be vigilant for depression after stroke and further routine screening may be worth considering. This is comparable to previous meta-analyses that have not confined their results to robust interview defined clinical disorders. 20 21 One recent meta-analysis examined anxiety disorders but included mixed scales and only 8 studies involved objective methods. We expand upon this to involve 25 studies of anxiety disorders. 22 When examined cross-sectionally, at precisely 12 months, we found that 13.5% had MDD and 23.9% any depressive disorder using pooled data. The clinical implication is that even a year after stroke, depression is significant. Future research should investigate the long-term burden of depression on patients and families.
Relatively few studies have examined anxiety disorders using interview methods. Of those, the prevalence of anxiety disorders was 9.9% (95% CI = 5.9% to 14.8%) with no clear difference in particular settings but 11.7% in a re-analysis using a non-overlapping sample. This is quite likely to be an underestimate, in part because not all studies measure all types of anxiety disorder, partially because depressive disorders receive most clinical attention and partially because criteria for GAD are currently very restrictive, requiring at least 6 months duration (note that some authors have purposely omitted this). 33 Unfortunately, the clinical significance of anxiety disorders after stroke, for example effect on daily function, effect on long-term recovery and interaction with major depression remains under studied. Once combined, the prevalence of any disorder of mood or emotion appears to be at least 30% although this is not a case of simple addition of the aforementioned categories because many types of mood disorder are comorbid. Future research should investigate not just the prevalence but also the impact of anxiety on rehabilitation and mortality.
We were only able to study possible risk factors for MDD, any depressive disorder and anxiety after stroke. There was insufficient data to study disease burden which appears influential according to previous research. 34 35 36 The relative risk of MDD was 50% higher (RR=1.50, 95% CI = 1.29 to 1.74) and the relative risk of any depressive disorder was 26% higher (RR=1.26, 95% CI = 1.16 to 1. ) found that the prevalence of depression in 2,477 participants at 4 months after stroke was 19% 37 and contrary to our results, they found that risk of depression reduced by duration post-stroke.
The clinical implication is that left (dominant) hemisphere stroke, aphasia, personal history and family history of mood disorders are the predominant known risk factors. Time since stroke is a weak risk factor and as such a high index of suspicions should be maintained even 5 years after a stroke, particularly where neurological complications persist.
We acknowledge the following limitations, which are largely accounted for by limitations in the primary studies. Despite the large sample size there were inadequate data in some subgroups and in some mood disorders, particularly adjustment disorders. There was also inadequate data to examine several potentially useful predictors of mood disorders such as disability, gender and quality of life and receipt of antidepressants; these should ideally be addressed in future studies. We acknowledge considerable heterogeneity in the sample and occasional evidence of publication bias (see table 1 ).
There were variations in the handling of aphasia, although we attempted to allow for this by clarifying studies examined point prevalence, meaning that transitions in to and out of remission were poorly described as were the total number of cases developing over a period of time (cumulative prevalence). We also note that stroke patients often have a high burden of physical symptoms and symptoms such as fatigue, anorexia and psychomotor retardation which may be caused by stroke or alternatively by depression. As such the phenomenology of post-stroke depression may be different to non-comorbid depression. That said most studies have found only minor differences in presentation. 38 39 . Finally, we only searched three electronic databases.
We conclude post-stroke disorders of mood or emotion appear to be common and highly comorbid.
Prevalence estimates do not appear to vary significantly with time but are typically higher in rehabilitation settings than in community settings. The key risk factors for post-stroke depression appear to be a past history of depression, a family history of depression, aphasia and left hemisphere lesions. Contrary to some previous reviews, 15 16 17 18 this more thorough quantitative analysis shows that lesion location is important for post-stroke depression but it is only one of many risk factors. The UK National Clinical Guidelines for Stroke recommend screening for depression within the first month of a stroke event; however, compliance with this is inconsistent. 40 Given the persistent nature of poststroke mood disorders we recommend clinical assessment and routine screening is extended to one year. We also recommend clinicians look for broadly defined mood disorders, anxiety and distress, not just major depression alone. 
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